Advertisement

Topics

Advanced Cell Technology Incorporated Company Profile

00:34 EDT 25th September 2017 | BioPortfolio

Advanced Cell Technology Announces License of its Cloning Patents to Immerge Biotherapeutics, INC., a Joint Venture Between Novartis Pharma Ag and Biotransplant, Inc. Worcester, MA, April 16, 2002—Advanced Cell Technology, Inc. (ACT) announced today the license of animal cloning technology to Immerge BioTherapeutics, Inc. of Charlestown, MA. The worldwide nonexclusive license will cover Immerge’s work in the development of genetically modified pigs for potential use in xenotransplantation (the use of animal organs to address human health issues). “We are excited to participate in a program that offers such hope for thousands of people,” said Michael D. West, Ph.D., President and C.E.O. of ACT. “Xenotransplantation may one day offer life-saving technology for people with kidney, lung, and heart failure and other degenerative diseases.” Immerge was formed as a joint venture between Novartis Pharma AG (NYSE:NVS) and BioTransplant, Incorporated (Nasdaq: BTRN) in September, 2000. Since that time, the company has reached two important milestones – the development of inbred miniature swine that are incapable of transmitting porcine retrovirus that can infect human cells and the development of the first knock-out cloned miniature swine. Both of these milestones have moved xenotransplantation closer to the clinic. Immerge has also previously announced a collaboration in pig nuclear transfer cloning with Infigen, Inc. “Cloning plays an important role in the further development of xenotransplantation and in the Immerge program,” said Julia Greenstein, Ph.D. President and C.E.O. of Immerge. “ACT’s technology will be an important enhancement to the intellectual property supporting our work.” The patents licensed to Immerge include U.S. Patent Nos. 6,235,970, 6,235,969, 6,215,041, and 5,945,577, the latter being the subject of an interference proceeding with Geron Corporation. Immerge will have the right to contract with third parties to manufacture product using ACT’s cloning technology. The need to find new sources for donor organs is a critical one, and the demand is growing each day. According to the United Network for Organ Sharing (UNOS), there are currently more than 79,000 people on the U.S. transplant waiting list and a new name is added to the list every 14 minutes. An equal number of prospective transplant patients never make the list because of the strict criteria needed to ensure that precious organs go to those candidates that are most likely to be successful recipients. Xenotransplantation offers the best hope for these people. Advanced Cell Technology is a biotechnology company focused on the discovery and commercialization of cloning technology for application in medicine and agriculture.

Location

1201 Harbor Bay Parkway
Suite 120
Alameda
94502
United States of America

Contact

Phone: 310.481.5124
Fax: 510.748.4950
Email: mwest@advancedcell.com


News Articles [3922 Associated News Articles listed on BioPortfolio]

Stem Cell and 3D Printing Generate Viable Tissue

A team of Swedish cell biologists combined three-dimensional (3D) bio-printing with advanced stem cell technology to create viable cultures of...

[News] NICE guidance on cabozantinib for previously treated advanced renal cell carcinoma

On August 9, 2017, the National Institute for Health and Care Excellence (NICE) published technology appraisal guidance1 recommending cabozantinib, within its marketing authorisation, as an option for...

Immunotherapy Safely Treats Advanced Squamous Cell Carcinoma

An anti–PD-1 monoclonal antibody is safe and effective for patients with unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma.

Opdivo in Combination with Yervo Demonstrates Improved Overall Survival for Advanced Renal Cell Carcinoma

A Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) in patients with previously untreated advanced or metastatic renal cell […] The post Opdivo in Combination with Yervo Demon...

Cell Medica boosts manufacturing capacity in cell therapy deal

The U.K. cell therapy company hopes to push forward with development of CGT Catapult's WT1 targeting T-cell receptor technology. 

Cell symposia on CRISPR: From biology to technology

(Cell Press) Juan Carlos Izpisua Belmonte of the Salk Institute for Biological Studies, whose lab was involved in a recent, successful effort to correct a gene mutation in human embryos, is one of a n...

Cancer Precision Immunotherapy Combination of Epacadostat plus Keytruda® Demonstrates Promise in Advanced Non-Small Cell Lung Cancer

Updated data from the advanced non-small cell lung cancer (NSCLC) group of an ongoing clinical trial evaluating epacadostat combined with […] The post Cancer Precision Immunotherapy Combination ...

EU approves ceritinib in ALK-positive advanced non-small cell lung cancer

The European Commission has approved expanding the use of ceritinib to include the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumours are anaplastic lymph...

PubMed Articles [8468 Associated PubMed Articles listed on BioPortfolio]

Application of single-cell technology in cancer research.

In this review, we have outlined the application of single-cell technology in cancer research. Single-cell technology has made encouraging progress in recent years and now provides the means to detect...

Lessons from single-cell transcriptome analysis of oxygen-sensing cells.

The advent of single-cell RNA-sequencing (RNA-Seq) technology has enabled transcriptome profiling of individual cells. Comprehensive gene expression analysis at the single-cell level has proven to be ...

Stem Cell Smart Technology, where are we now and how far we have to go?

Approximately eight million people in the United States have peripheral arterial disease, which increases exponentially with age. There have been a plethora of available treatments including surgery, ...

Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence?

There are few randomized controlled studies to guide the treatment of advanced cutaneous squamous cell carcinoma. The existing treatments are mostly based on case reports and small case series. Here w...

An Expert Opinion on Advanced Insulin Pump Use in Youth with Type 1 Diabetes.

Among children and adolescents with type 1 diabetes mellitus, the use of insulin pump therapy has increased since its introduction in the early 1980s. Optimal management of type 1 diabetes mellitus de...

Clinical Trials [9978 Associated Clinical Trials listed on BioPortfolio]

User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™

The primary aim of this study is to demonstrate the maintenance of healthy peri-stomal skin over a two month period in subjects who use ConvaTec Moldable Technology™ Skin Barriers as par...

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

The purpose of the study is to compare the clinical benefit, as measured by duration of overall survival, of Nivolumab vs. Everolimus in subjects with advanced or metastatic clear-cell ren...

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors

The proposed clinical trial is a phase I, open-label, multi-center, dose-escalation study of ALT-803 in patients with surgically incurable advanced solid tumors: melanoma, renal cell, non-...

Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.

RT-View utilizes spectral domain technology to assess both RNFL and ganglion cell layer thickness. This study aims to correlate visual field defects in patients with glaucoma to both RNFL ...

Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

The clinical outcome of advanced / metastatic renal cell carcinoma has been changed since targeted therapy being widely applied. This study will retrospectively analyse the clinical outcom...

Companies [2678 Associated Companies listed on BioPortfolio]

Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.c...

3D Biotek

Founded in April 2007, 3D Biotek LLC is a biotechnology company located in New Jersey, USA. Using its Precision 3D Micro-Fabrication Technology and Advanced Bio-Manufacturing Tech...

ADVANCED CELL & GENE THERAPY, LLC

ADVANCED CELL & GENE THERAPY, LLC, is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. We provide practical, experienced guidance in development, ...

R-JAPAN Co., Ltd.

R-JAPAN Co., Ltd. is the advanced biotechnology company specialized in manufacturing mesenchymal stem cells regenerative therapy with stem cell technology of Biostar Stem c...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

More Information about "Advanced Cell Technology Incorporated" on BioPortfolio

We have published hundreds of Advanced Cell Technology Incorporated news stories on BioPortfolio along with dozens of Advanced Cell Technology Incorporated Clinical Trials and PubMed Articles about Advanced Cell Technology Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Cell Technology Incorporated Companies in our database. You can also find out about relevant Advanced Cell Technology Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cloning
Cloning in biology is the process of producing similar populations of genetically identical individuals that occurs in nature when organisms such as bacteria, insects or plants reproduce asexually. Cloning in biotechnology refers to processes used to cre...


Corporate Database Quicklinks



Searches Linking to this Company Record